The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population- an updated meta-analysis-Reference-Cited by-同舟云学术

The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population- an updated meta-analysis

Published:2014-12 Issue:1 Volume:14 Page:
ISSN:1471-2377
Container-title:BMC Neurology
language:en
Short-container-title:BMC Neurol

Author:

Shi LiGen,Pu JiaLi,Xu Liang,Malaguit Jay,Zhang Jianmin,Chen Sheng

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),General Medicine

Link

http://link.springer.com/article/10.1186/s12883-014-0251-7/fulltext.html

Reference36 articles.

1. Murray CJ, Lopez AD: Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet. 1997, 349: 1436-1442. 10.1016/S0140-6736(96)07495-8.

2. Huang Y, Cheng Y, Wu J, Li Y, Xu E, Hong Z, Li Z, Zhang W, Ding M, Gao X, Fan D, Zeng J, Wong K, Lu C, Xiao J, Yao C: Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study. Lancet Neurol. 2008, 7: 494-499. 10.1016/S1474-4422(08)70094-2.

3. Pendlebury ST, Rothwell PM: Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009, 8: 1006-1018. 10.1016/S1474-4422(09)70236-4.

4. Guo JJ, Xu E, Lin QY, Zeng GL, Xie HF: Effect of cilostazol on cerebral arteries in secondary prevention of ischemic stroke. Neurosci Bull. 2009, 25: 383-390. 10.1007/s12264-009-6192-2.

5. Estol CJ, Bath PM, Gorelick PB, Cotton D, Martin RH, Committee PRP, Investigators PR: Differences in ischemic and hemorrhagic recurrence rates among race-ethnic groups in the PRoFESS secondary stroke prevention trial. Int J Stroke 2014, Suppl A100:43–47.,

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cilostazol may be a better therapeutic agent for acute ischemic stroke because of its efficacy in preventing post-stroke depression;2023-10-31

2. Long-term effectiveness and safety of cilostazol versus clopidogrel in secondary prevention of noncardioembolic ischemic stroke;European Journal of Clinical Pharmacology;2023-06-13

3. Long-Term Comparison of Cilostazol versus Clopidogrel in Secondary Prevention of Noncardioembolic Ischemic Stroke;2023-02-08

4. The Efficacy and Safety of Ischemic Stroke Therapies: An Umbrella Review;Frontiers in Pharmacology;2022-07-22

5. The Efficacy and Safety of Cilostazol vs. Aspirin for Secondary Stroke Prevention: A Systematic Review and Meta-Analysis;Frontiers in Neurology;2022-02-15